| |
|
小峰 光博 |
昭和大学藤が丘病院血液内科 客員教授 |
| 血液病学 |
| Long-term outcome of patients with acquired chronic pure red cell aplasia(PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA study group. Hirokawa M, Sawada K, Omine M, et al. Br J Haematol 2015 Mar 25. Doi:10.1111/bjh.13376 |
| Lon-term efficacy and safety of eculizumab in Japanese patients with PNH : AEGIS trial. Kanakura Y, Nishimura J, Omine M, et al. Int J Hematol 98:406-416, 2013 |
| Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Sanada M, Omine M, Ogawa S, et al. Nature 2009, 460:904-908 |
|
| |
|
齋藤英彦 |
国立病院機構名古屋医療センター・名誉院長 |
| 内科学、血液学、造血幹細胞移植 |
| Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation. Yazaki M, Atsuta Y, Kato K, Kato S, Taniguchi S, Takahashi S, Ogawa H, Kouzai Y, Kobayashi T, Inoue M, Kobayashi R, Nagamura-Inoue T, Azuma H, Takanashi M, Kai S, Nakabayashi M, Saito H. Biol Blood Marrow Transplant 15: 439-446, 2009 |
Adachi T, Matsushita T , Ichihashi R, Hirashima K, Ito M, Inukai A, Yokozawa T, Nishida T, Nishida T, Murata M, Hayashi M, Katsumi A, Kojima T, Saito H, Naoe T. High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogenic hematopoietic stem cell transplantation.
Int J Hematol 83：415-419, 2006
|
齋藤英彦：骨髄バンク・さい帯血バンク事業の課題と展望
公衆衛生：77：648−652、2013
|
|
| ○ |
|
野本 亀久雄 |
公益社団法人日本臓器移植ネットワーク 理事長 |
| 生体防御論 |
＜研究論文例＞
Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice.
(J.immunol 150：753-762,1993)
|
＜著作例＞
Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.
(Immunology 78:113-121,1993)
|
＜学術的発表例＞
Tolerance induction in a tully allogeneic combination using anti-T-cell receptor- alpha beta monoclonal antibody, low dose irradiation，and bone marrow transfusion.
(Transplantation,:395-401,1995.)
|
|
| |
|
松田 暉 |
公益財団法人神戸国際交流財団 理事長 |
| 心臓血管外科、臓器移植 |
（著作）
心臓移植 松田 暉監修、SpringerJapan 社(現在、丸善) 2011
|
(研究業績−１)
Clinical results with Jarvik 2000 axial flow left ventricular assist device:Osaka University Experience.Yoshioka D, Matsumiya G, Toda K, Sakaguchi T, Yoshikawa Y, Saito S,Matsuda H, Sawa Y.
J Artif Organs. 2014 Dec;17(4):308-14.
|
（研究業績２）
Combined strategy using myoblasts and hepatocyte growth factor in dilated cardiomyopathic hamsters.Kondoh H, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Kitagawa-Sakakida S, Imanishi Y, Kawaguchi N, Matsuura N, Matsuda H.
Ann Thorac Surg. 2007 Jul;84(1):134-41.
|
|
| |
|
門田守人 |
公益財団法人がん研究会有明病院・病院長 |
| 外科学・臓器移植学 |
Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
Ritchie SA, Akita H, Takemasa I, Eguchi H, Pastural E, Nagano H, Monden M, Doki Y, Mori M, Jin W, Sajobi TT, Jayasinghe D, Chitou B, Yamazaki Y, White T, Goodenowe DB.
BMC Cancer. 2013 Sep 12;13:416.
|
Evolution of registry and tracking system for organ transplantation in Japan.
Yuzawa K, Takahara S, Kanmochi T, Takahashio K, Umeshita H, Monden M, Teraoka S.
Transplant Proc. 2012 May;44(4):828-31
|
Steroid-free living donor liver transplantation for HCV--a multicenter prospective cohort study in Japan.
Marubashi S, Umeshita K, Asahara T, Fujiwara K, Haga H, Hashimoto T, Hatakeyama K, Ichida T, Kanematsu T, Kitajima M, Kiyosawa K, Makuuchi M, Miyagawa S, Satomi S, Soejima Y, Takada Y, Tanaka N, Teraoka S, Monden M.
Clin Transplant. 2012 Nov-Dec;26(6):857-67.
|
|
| |
|
山口照英 |
国立医薬品食品衛生研究所・主任研究官 |
| 再生医療・遺伝子治療・バイオ医薬品 |
| A New Role of Thrombopoietin Enhancing ex Vivo Expansion of Endothelial Precursor Cells Derived from AC133-positive Cells. Kanayasu-Toyoda, T., Ishii-Watabe, A., Suzuki, T., Oshizawa, T., & Yamaguchi, T. The Journal of biological chemistry 282, 33507-33514. (2007) |
| Angiogenic Role of MMP-2/9 Expressed on the Cell Surface of Early Endothelial Progenitor Cells/Myeloid Angiogenic Cells. Kanayasu-Toyoda,T, Tanaka,T, Ishii-Watabe,A, Kitagawa,H, Matsuyama,A, Uchida,E, Yamaguchi,T. J Cell Physiol. doi: 10.1002/jcp.25002. (2015) |
Angiogenic cell therapy for severe ischemic diseases. Yamaguchi,T, Kanayasu-Toyoda, T, Uchida,E. Biol Pharm Bull. 36(2):176-81. (2013)
|
|
